| Popis: |
Epidemiological data revealed an increasing consume of both ‘legal’ (i.e. tobacco, alcohol) and illegal substances amongst women of childbearing age, during the last decades, with a subsequent increasing risk of teratogenesis and perinatal complications for foetus of pregnant women exposed to substances of abuse/misuse. The early identification and management of women at risk of substance use disorders (SUDs) in pregnancy may help clinicians in promptly applying specifically targeted harm reduction interventions. The present chapter aims at providing a comprehensive overview on birth defects, foetal malformations, teratogenic risk and perinatal complications related to the consumption of cannabinoids, opioids and psychostimulant drugs during pregnancy. Practical recommendations on how to manage a pregnant woman with a SUD (with and/or without a comorbid psychiatric disorder) have been as well here provided, from a pharmacological and nonpharmacological point of view. |
